References
- SarafidisK. Renal consequences of perinatal asphyxia: the role of urinary biomarkers. In: Fanos V, Chevalier RL, Faa G, Cataldi L, eds. Developmental Nephrology: from embryology to metabolomics. Quartu Sant’Elena, Italy: Hygeya Press; 2011:182–93
- Shah P, Riphagen S, Beyene J, Perlman M. Multiorgan dysfunction in infants with post-asphyxial hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 2004;89:152–5
- Fanos V, Atzori L, Dessì A, et al. The kidney in post-asphyctic syndrome: state of the art. In: Fanos V, Chevalier RL, Faa G, Cataldi L, eds. Developmental Nephrology: from embryology to metabolomics. Quartu Sant’Elena, Italy: Hygeya Press; 2011:159–79
- Bestati N, Leteurtre S, Duhamel A, et al. Differences in organ dysfunctions between neonates and older children: a prospective, observational, multicenter study. Crit Care 2010;14:1--9
- Aroni F, Xanthos T, Varsami M, et al. An experimental model of neonatal normocapnic hypoxia and resuscitation in Landrace/Large white piglets. J Matern Fetal Neonatal Med 2012;25:1750–4
- Faa A, Iacovidou N, Xanthos T, et al. Hypoixia/reoxygenation-induced myocardial lesions in newborn piglets are related to interindividual variability and not to oxygen concentration. Clinics 2012;67:503–8
- Zhao P, Gao S, Lin B. Elevated levels of serum S100B is associated with the presence and outcome of haemorrhagic shock. Clin Lab 2012;58:1051–5
- Tsoporis JN, Marks A, Haddad A, et al. S100b expression modulates left ventricular remodeling after myocardial infarction in mice. Circulation 2005;111:598–606
- Faa A, Senes G, Locci A, et al. S100B protein expression in the heart of deceased individuals by overdose: a new forensic marker? Clinics 2012;67:821–6
- Haimoto H, Hosoda S, Kato K. Differential distribution of immunoreactive S100-alpha and S100-beta proteins in normal non-nervous human tissues. Lab Invest 1987;57:489–98
- Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochimica and Biophysica Acta 2009;1793:993–1007
- Li DR, Ishikawa T, Zhao D, et al. Postmortem serum protein S100B levels with regard to the cause of death involving brain damage in medicolegal autopsy cases. Legal Med 2006;8:71–7
- Wunderlich MT, Wallesch CW, Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci 2004;227:49–53
- Weiss N, Sanchez Pena P, Roche S, et al. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology 2006;104:658–66
- Gazzolo D, Marinoni E, Di Iorio R, et al. Urinary S100B protein measurements: a tool for the early identification of hypoxic-ischemic encefalopathy in asphyxiated full-term infants. Crit Care Med 2004;32:131–6
- Johnsonn P, Backstrom M, Bergh C, et al. Increased S100B in blood after cardiac surgery is a powerful predictor of late mortality. Ann Thorac Surg 2003;75:162–8
- Gazzolo D, Florio P, Ciotti S, et al. S100B protein in urine of preterm newborns with ominous out come. Pediatrich Research 2005;58:1170–5
- Kleine OT, Benes L, Zöfel P. Studies of the brain specificity of S100B and neuron-specific enolase (NSE) in blood serum of acute care patients. Brain Res Bull 2003;61:265–79
- Anderson RE, Hansson LO, Nilsson O, et al. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001;48:1255–8